Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandrasekhar Bal

Showing results (11-20 of 328) with videos related to

Pageof 33
Sort By:
Clinical Endocrinology|December 5, 2023
Impact of radioiodine therapy on recurrence and survival outcomes in intermediate-risk papillary thyroid carcinoma -A systematic review and meta-analysisKunal Ramesh Chandekar, Swayamjeet Satapathy, Chandrasekhar Bal
Journal of Vascular and Interventional Radiology : JVIR|January 18, 2006
Management of postsurgical recurrence of hepatocellular carcinoma with rhenium 188-HDD labeled iodized oilAjay Kumar, Deep N Srivastava, Chandrasekhar Bal
Indian Journal of Surgical Oncology|December 4, 2012
Role of F18-FDG PET/CT in the Staging and Restaging of Esophageal Cancer: A Comparison with CECTPraveen Kumar, Nishikant A Damle, Chandrasekhar Bal
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 11, 2023
[<sup>177</sup>Lu]Lu-PSMA-Radioligand Therapy Efficacy Outcomes in Taxane-Naïve Versus Taxane-Treated Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and MetaanalysisSwayamjeet Satapathy, Ranjit K Sahoo, Chandrasekhar Bal
The Journal of Clinical Endocrinology and Metabolism|January 12, 2024
Optimal Cumulative I-131 Activity in Metastatic Differentiated Thyroid Cancer: Balancing Efficacy and Adverse EventsMangu Srinivas Bharadwaj, Sanjana Ballal, Chandrasekhar Bal
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|April 28, 2025
Optimal Time of Diagnostic and Posttherapeutic Iodine-131 Whole-body Scan in Post-Operative Pediatric and Young Adult Differentiated Thyroid Cancer PatientsPraveen Kumar, Chandrasekhar Bal, Nishikant Avinash Damle
EJNMMI Research|February 7, 2019
Concomitant <sup>177</sup>Lu-DOTATATE and capecitabine therapy in malignant paragangliomasMadhav Prasad Yadav, Sanjana Ballal, Chandrasekhar Bal
Clinical Nuclear Medicine|October 14, 2022
Radioiodine Therapy in Pediatric Differentiated Thyroid Cancer: Dosimetry, Clinical Care, and Future ChallengesPraveen Kumar, Nishikant Avinash Damle, Chandrasekhar Bal
Clinical Nuclear Medicine|January 23, 2025
Utility of Novel Radiohybrid PSMA Ligands in PET Imaging of Biochemical Recurrence of Prostate Cancer-A Systematic Review and Meta-analysisKunal Ramesh Chandekar, Swayamjeet Satapathy, Chandrasekhar Bal
PET Clinics|January 11, 2024
Positron Emission Tomography/Computed Tomography in Thyroid Cancer: An Updated ReviewKunal Ramesh Chandekar, Swayamjeet Satapathy, Chandrasekhar Bal
Pageof 33

Showing results (11-20 of 328) with videos related to

Sort By:
Pageof 33
Clinical Endocrinology|December 5, 2023
Impact of radioiodine therapy on recurrence and survival outcomes in intermediate-risk papillary thyroid carcinoma -A systematic review and meta-analysisKunal Ramesh Chandekar, Swayamjeet Satapathy, Chandrasekhar Bal
Journal of Vascular and Interventional Radiology : JVIR|January 18, 2006
Management of postsurgical recurrence of hepatocellular carcinoma with rhenium 188-HDD labeled iodized oilAjay Kumar, Deep N Srivastava, Chandrasekhar Bal
Indian Journal of Surgical Oncology|December 4, 2012
Role of F18-FDG PET/CT in the Staging and Restaging of Esophageal Cancer: A Comparison with CECTPraveen Kumar, Nishikant A Damle, Chandrasekhar Bal
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 11, 2023
[<sup>177</sup>Lu]Lu-PSMA-Radioligand Therapy Efficacy Outcomes in Taxane-Naïve Versus Taxane-Treated Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and MetaanalysisSwayamjeet Satapathy, Ranjit K Sahoo, Chandrasekhar Bal
The Journal of Clinical Endocrinology and Metabolism|January 12, 2024
Optimal Cumulative I-131 Activity in Metastatic Differentiated Thyroid Cancer: Balancing Efficacy and Adverse EventsMangu Srinivas Bharadwaj, Sanjana Ballal, Chandrasekhar Bal
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|April 28, 2025
Optimal Time of Diagnostic and Posttherapeutic Iodine-131 Whole-body Scan in Post-Operative Pediatric and Young Adult Differentiated Thyroid Cancer PatientsPraveen Kumar, Chandrasekhar Bal, Nishikant Avinash Damle
EJNMMI Research|February 7, 2019
Concomitant <sup>177</sup>Lu-DOTATATE and capecitabine therapy in malignant paragangliomasMadhav Prasad Yadav, Sanjana Ballal, Chandrasekhar Bal
Clinical Nuclear Medicine|October 14, 2022
Radioiodine Therapy in Pediatric Differentiated Thyroid Cancer: Dosimetry, Clinical Care, and Future ChallengesPraveen Kumar, Nishikant Avinash Damle, Chandrasekhar Bal
Clinical Nuclear Medicine|January 23, 2025
Utility of Novel Radiohybrid PSMA Ligands in PET Imaging of Biochemical Recurrence of Prostate Cancer-A Systematic Review and Meta-analysisKunal Ramesh Chandekar, Swayamjeet Satapathy, Chandrasekhar Bal
PET Clinics|January 11, 2024
Positron Emission Tomography/Computed Tomography in Thyroid Cancer: An Updated ReviewKunal Ramesh Chandekar, Swayamjeet Satapathy, Chandrasekhar Bal
Pageof 33